Purinergic transmission in depressive disorders

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• Purinergic signaling encompasses the actions of nucleotides/nucleosides like adenosine at P1 (adenosine) and P2 (P2X, P2Y) receptors.
• These receptors and their ligands play crucial roles in central nervous system functions.

Purpose of the Study:

• To provide a comprehensive overview of the association between purinergic signaling and depression.
• To highlight potential roles of adenosine metabolism and P1/P2 receptors in depression.

Main Methods:

• Review of background on adenosine metabolism and P1/P2 receptor characterization (expression, function, ligands).
• Analysis of preclinical/behavioral data from depression models (e.g., forced swim test, chronic mild stress).
• Examination of studies involving genetic manipulation or pharmacological targeting of purinergic receptors.

Main Results:

• Evidence suggests altered adenosine metabolism in depressed patients, potentially indicating a biomarker.
• Preclinical studies using various models and receptor manipulations show significant associations between purinergic signaling and depressive behaviors.
• Discrepancies in study findings were also addressed.

Conclusions:

• Purinergic signaling, particularly involving adenosine pathways, is strongly implicated in depression.
• Adenosine metabolism alterations and P1/P2 receptor modulation represent promising avenues for depression research and potential therapeutic strategies.